Abstract
In CALGB 9082, patients with breast cancer involving ≥10 axillary nodes without evidence of distant metastasis received 4 cycles of induction CAF chemo and were then randomized to receive either high dose cyclophosphamide, cisplatin, BCNU with autologous marrow/stem-cell support or intermediate-doses of the same drugs. All patients were prescribed to receive local-regional RT following chemo. We herein assess whether there was an association of overall survival with (1) receipt of RT and (2) the timeliness of RT among irradiated patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have